0001209191-16-155681.txt : 20161216 0001209191-16-155681.hdr.sgml : 20161216 20161216170116 ACCESSION NUMBER: 0001209191-16-155681 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20161214 FILED AS OF DATE: 20161216 DATE AS OF CHANGE: 20161216 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Minerva Neurosciences, Inc. CENTRAL INDEX KEY: 0001598646 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 260784194 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1601 TRAPELO ROAD STREET 2: SUITE 284 CITY: WALTHAM STATE: MA ZIP: 02451 BUSINESS PHONE: 617-600-7373 MAIL ADDRESS: STREET 1: 1601 TRAPELO ROAD STREET 2: SUITE 284 CITY: WALTHAM STATE: MA ZIP: 02451 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Levine Mark S. CENTRAL INDEX KEY: 0001617236 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36517 FILM NUMBER: 162056979 MAIL ADDRESS: STREET 1: 1601 TRAPELO ROAD STREET 2: SUITE 284 CITY: WALTHAM STATE: MA ZIP: 02451 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2016-12-14 0 0001598646 Minerva Neurosciences, Inc. NERV 0001617236 Levine Mark S. C/O MINERVA NEUROSCIENCES, INC. 1601 TRAPELO ROAD, SUITE 284 WALTHAM MA 02451 0 1 0 0 SVP,General Counsel & Sec. Restricted Stock Units 2016-12-14 4 A 0 20000 0.00 A Common Stock 20000 20000 D Employee Stock Option (Right to Buy) 13.45 2016-12-14 4 A 0 35000 0.00 A 2026-12-13 Common Stock 35000 35000 D Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock Represents shares issuable upon the vesting of restricted stock units ("RSUs") awarded to the Reporting Person on December 14, 2016. The RSUs vest in 4 equal annual installments beginning on December 14, 2017 and will be fully vested on December 14, 2020, in all cases so long as there has been no break in the Reporting Person's continuous service through such date. The exercise price is the closing price of the Issuer's common stock on December 14, 2016. This option shall vest as follows: 25% on December 14, 2017 and then in quarterly installments over 3 years thereafter. /s/ Mark Levine 2016-12-16